| ID | PMID | SEQUENCE | NAME | LENGTH | ACTIVITY |
| 1104 | 18617323 | RAGLQFPVGRLLRRLLRRLLR | Buforin IIb | 21 | IC50=14.6 µg/ml |
| 1547 | 18656352 | KAQIRAMECNIL | A5 | 12 | Not Available |
| 1548 | 18656352 | RKKRRQRRR | Tat | 9 | ~10% Cytotoxicity at 100 µM |
| 1549 | 18656352 | KAQIRAMECNILGRKKRRQRRR | Tat-a5 | 22 | ~80% Cytotoxicity at 100 µM |
| 3159 | 23301519 | WRWRWRWRW | Cyclic [W(RW)4 ]-Dox | 9 | 50-67% inhibition of cell proliferation at 1 µM |
| 3163 | 23301519 | RWRWRWRW | linear (RW)4-Dox | 8 | 21-61% antiproliferative activity at 1 µM |
| 3228 | 22644847 | FLGWLFKWAWK | GA-W3 | 11 | IC50 =24.63 µM |
| 3235 | 22644847 | FLWWLFKWAWK | GA-W4 | 11 | IC50 =14.80 µM |
| 3242 | 22644847 | FLGWLFKWAKK | GA-K3 | 11 | IC50 =27.00 µM |
| 3249 | 22644847 | FLKWLFKWAKK | GA-K4 | 11 | IC50 =14.80 µM |
| 3398 | None | NHFTLKCPKTALTEPPTLAY | TG20 | 20 | 20% cytotoxicity at 1 µM |
| 3399 | None | NHFTLKCPKTALTEPPTLAY | TG20 | 20 | 10% cytotoxicity at 10 µM |
| 3400 | None | NHFTLKCPKTALTEPPTLAY | TG20 | 20 | <5% cytotoxicity at 1 µM |
| 3401 | None | NHFTLKCPKTALTEPPTLAY | TG20 | 20 | <3% cytotoxicity at 10 µM |
| 3402 | None | NHFTLKCPKTALTEPPTLAY | TG20 | 20 | <20% cytotoxicity at 1 µM |
| 3403 | None | NHFTLKCPKTALTEPPTLAY | TG20 | 20 | 15% cytotoxicity at 10 µM |
| 3404 | None | TAGIKLTVPIEKFPVTTQTFWG | TG23 | 22 | <15% cytotoxicity at 1 µM |
| 3405 | None | TAGIKLTVPIEKFPVTTQTFWG | TG23 | 22 | 15% cytotoxicity at 10 µM |
| 3406 | None | TAGIKLTVPIEKFPVTTQTFWG | TG23 | 22 | ~5% cytotoxicity at 1 µM |
| 3407 | None | TAGIKLTVPIEKFPVTTQTFWG | TG23 | 22 | <5% cytotoxicity at 10 µM |
| 3408 | None | TAGIKLTVPIEKFPVTTQTFWG | TG23 | 22 | <5% cytotoxicity at 1 µM |
| 3409 | None | TAGIKLTVPIEKFPVTTQTFWG | TG23 | 22 | <5% cytotoxicity at 10 µM |
| 3410 | None | GQVWEATATVNAIRGSVTPAVSQFNARTAD | MB30 | 30 | >40% cytotoxicity at 1 µM |
| 3411 | None | GQVWEATATVNAIRGSVTPAVSQFNARTAD | MB30 | 30 | 50% cytotoxicity at 10 µM |
| 3412 | None | GQVWEATATVNAIRGSVTPAVSQFNARTAD | MB30 | 30 | <20% cytotoxicity at 1 µM |
| 3413 | None | GQVWEATATVNAIRGSVTPAVSQFNARTAD | MB30 | 30 | >20% cytotoxicity at 10 µM |
| 3414 | None | GQVWEATATVNAIRGSVTPAVSQFNARTAD | MB30 | 30 | >30% cytotoxicity at 1 µM |
| 3415 | None | GQVWEATATVNAIRGSVTPAVSQFNARTAD | MB30 | 30 | ~40% cytotoxicity at 10 µM |
| 3724 | 9815815 | fA*YwKA*T | Lan-7 | 7 | IC50= 29.97±1.19 µM |
| 3729 | 22644847 | FLGWLFKWAWK | GA-W3 | 11 | IC50= 24.63 µM |
| 3736 | 22644847 | FLWWLFKWAWK | GA-W4 | 11 | IC50= 14.80 µM |
| 3743 | 22644847 | FLGWLFKWAKK | GA-K3 | 11 | IC50= 27.00 µM |
| 3750 | 22644847 | FLKWLFKWAKK | GA-K4 | 11 | IC50= 14.8 µM |
| 4578 | 21423613 | PRFWEYWLRLME | MIP | 12 | IC50 =0.01 µM |
| 4579 | 21423613 | LTFEHYWAQLTS | DI | 12 | IC50 =0.29 µM |
| 4580 | 21423613 | LTAEHYAAQATS | 3A | 12 | IC50 >100 µM |
| 4581 | 21423613 | QETFSDLWKLLP | P5317-28 | 12 | IC50 =4.7 µM |
| 4582 | 21423613 | PRAWEYWLRLME | MIP(F3A) | 12 | IC50 =0.57 µM |
| 4583 | 21423613 | PRFWEAWLRLME | MIP(Y6A) | 12 | IC50 >100 µM |
| 4584 | 21423613 | PRFWEYALRLME | MIP(W7A) | 12 | IC50 >100 µM |
| 4585 | 21423613 | PRFWEYWLALME | MIP(R9A) | 12 | IC50 =0.02 µM |
| 4586 | 21423613 | PRFWEYWLRAME | MIP(L10A) | 12 | IC50 =1.14 µM |
| 4587 | 21423613 | PRFWEYWLRLAE | MIP(M11A) | 12 | IC50 =0.4 µM |
| 4588 | 21423613 | PRFWEYWLRLME | MIP | 12 | IC50 =0.12 µM |
| 4589 | 21423613 | LTFEHYWAQLTS | DI | 12 | IC50 =1.6 µM |
| 4590 | 21423613 | LTAEHYAAQATS | 3A | 12 | IC50 >100 µM |
| 4591 | 21423613 | QETFSDLWKLLP | P5317-28 | 12 | IC50 =30 µM |
| 5016 | 24962950 | KILRGVAKKIMRTFLRRISKDILTGKK | C7A | 27 | Cell viability >50% at 25μM approx |
| 5017 | 24962950 | KILRGVAKKIMRTFLRRISKKILTGKK | C7A-D21K | 27 | Cell viability =50% at 12.5μM approx. |
| 5018 | 24962950 | KILRGVAKKIMRTFLRRISKDILTGKK | C7A-Δ | 27 | Cell viability >50% at 12.5μM approx. |
| 5031 | 24962950 | KILRGVAKKIMRTFLRRISKDILTGKK | C7A | 27 | Cell viability >40% at 12.5μM approx |
| 5032 | 24962950 | KILRGVAKKIMRTFLRRISKKILTGKK | C7A-D21K | 27 | Cell viability >40% at 12.5μM approx |
| 5033 | 24962950 | KILRGVAKKIMRTFLRRISKDILTGKK | C7A-Δ | 27 | Cell viability >50% at 12.5μM approx |